Clinical course of breast cancer patients with metastases confined to the lungs treated with chemotherapy

Annals of Oncology

Volumn 9, Issue 4, 1998, Pages 413-418

  Diaz Canton, E A ^a   Valero, V ^a,b   Rahman, Z ^a   Rodriguez Monge, E ^a   Frye, D ^a   Smith, T ^a   Buzdar, A U ^a   Hortobagyi, G N ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast cancer; Chemotherapy; Lungs; Metastases

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SURVIVAL; DISEASE COURSE; FEMALE; HUMAN; LUNG METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0031798430     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008205522875     Document Type: Article

References (27)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. Cancer J Clin 1996; 65: 5-27.
2. Legha SS, Buzdar AU, Smith TL et al. Complete remissions in metastatic breast cancer treated with combination drug therapy. Ann Intern Med 1979; 91: 847-52.
3. Ross MB, Buzdar AU, Smith TL. Improved survival of patients with metastatic breast cancer receiving combination chemotherapy. Cancer 1985; 55: 341-6.
4. Henderson IC, Canellos GP. Cancer of the breast. the past decade. N Engl J Med 1980; 302: 78-88.
5. Canellos GP, Pocock SJ,Taylor SG et al. Combination chemotherapy for metastatic breast carcinoma. Cancer 1976; 38: 1882-6.
6. Swenerton KD, Legha SS, Smith TL et al. Prognostic factors in metastatic breast cancer treated with combination chemotherapy. Cancer Res 1979; 39: 1552-62.
7. Y-TN Lee. Breast carcinoma: Pattern of metastasis at autopsy. J Surg Oncol 1983; 23: 175-80.
8. Ingle JN. Principles of treatment in advanced breast cancer. Hematol-Oncol Clin N Am 1989; 3 (4): 743-63.
9. Cutler SJ, Asire AJ, Taylor SG III. Classification of patients with disseminated cancer of the breast. Cancer 1969; 24: 861-9.
10. Staren ED, Salerno C, Rongione A et al. Pulmonary resection for metastatic breast cancer. Arch Surg 1992; 127: 1282-4.
11. Lanza LA, Natarjan G, Roth JA et al. Long-term survival after resection of pulmonary metastases from carcinoma of the breast. Ann Thorac Surg 1992; 54: 244-8.
12. Wright JO, Brandt B, Ehrenhaft JL. Results of pulmonary resection for metastatic lesions. J Thorac Cardiovasc Surg 1982; 83: 94-9.
13. McCormack PM, Martini N. The changing role of surgery for pulmonary metastases. Ann Thorac Surg 1978; 28 (2): 139-45.
14. Mountain CF, McMurtrey MJ, Hermes KE. Surgery for pulmonary metastases: A 20-year experience. Ann Thorac Surg 1984; 38 (4): 323-30.
15. Marincola FM, Mark JBD. Selection factors resulting in improved survival after surgical resection of tumors metastatic to the lungs. Arch Surg 1990; 125: 1387-93.
16. McDonald ML, Deschamps C, Ilstrup DM et al. Pulmonary resection for metastatic breast cancer. Ann Thorac Surg 1994; 58: 1599-602.
17. Gehan E. A generalized Wilcoxon test for comparing arbitrarily single-censored samples. Biometrika 1965; 52: 203-24.
18. Breslow N. A generalized Kruskal-Wallis test for comparing samples subject to unequal patterns of censorship. Biometrika 1970; 57: 579-94.
19. Pass HI. Treatment of metastatic cancer to the lung. In De Vita VT Jr. Hellman S, Rosemberg SA (eds): Cancer: Principles and Practice of Oncology, 4th edition. Philadelphia. PA: Lippincott 1993.
20. Whitehouse JMA. Site-dependent response to chemotherapy for carcinoma of the breast. J Royal Soc Med 1985; 78 (Suppl 9): 18-22.
21. Perez-Manga G, Lara Alvarez MA, Arranz Arija JA et al. Long-term survivors without intensive therapy in metastatic breast cancer with nodular lung metastases as only site of relapse. Proc Eur Soc Clin Oncol 1994; 142.
22. Zinser JW, Hortobagyi GN, Buzdar AU et al. Clinical Course of Breast Cancer Patients with Liver Metastases. J Clin Oncol 1987; 5: 773-82.
23. Scheid V, Buzdar AU, Smith TL, Hortobagyi GN. Clinical course of breast cancer patients with osseous metastasis treated with combination chemotherapy. Cancer 1986; 58: 2589-93.
24. Friedel G, Linder A, Toomes H. The significance of prognostic factors for the resection of pulmonary metastases of breast cancer. Thorac Cardiovasc Surg 1994; 42 (2): 71-5.
25. Dunphy F, Spitzer G, Rossiter Fornoff JE et al. Factors predicting long-term survival for metastatic breast cancer patients treated with high-dose chemotherapy and bone marrow support. Cancer 1994; 73: 2157-67.
26. Peters WP, Shpall EJ, Jones RB et al. High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol 1988; 6: 1368-76.
27. Bezwoda WR, Seymour L, Dansey RD. High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: A randomized trial. J Clin Oncol 1995; 13: 2483-9.